ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG Trademark

Trademark Overview


On Thursday, October 29, 2020, a trademark application was filed for ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG with the United States Patent and Trademark Office. The USPTO has given the ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG trademark a serial number of 90287810. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 29, 2022. This trademark is owned by Supernus Pharmaceuticals, Inc.. The ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
once-daily qelbree viloxazine extended-release capsules 100 mg 150 mg 200 mg

General Information


Serial Number90287810
Word MarkONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG
Filing DateThursday, October 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 29, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements


Description of MarkThe mark consists of the horizontally-situated literal element "ONCE-DAILY"; a diamond shape to the right of "ONCE-DAILY"; the literal element "QELBREE" under "ONCE-DAILY"; the literal element "VILOXAZINE" underneath "QELBREE"; the literal element "EXTENDED-RELEASE CAPSULES" underneath "VILOXAZINE"; and the literal element "100 MG 150 MG 200 MG" underneath "EXTENDED-RELEASE CAPSULES".
Goods and ServicesPharmaceutical preparations for therapeutic use in humans, namely, for the treatment and prevention of central nervous system and peripheral nervous system diseases and disorders, psychiatric and neurological diseases and disorders; all containing Viloxazine
Pseudo MarkONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE HUNDRED MILLIGRAM ONE HUNDRED FIFTY MILLIGRAM TWO HUNDRED MILLIGRAM; ONCE-DAILY QELBREE VILOXAZINE EXTENDED-RELEASE CAPSULES ONE ZERO ZERO MILLIGRAM ONE FIVE ZERO MILLIGRAM TWO ZERO ZERO MILLIGRAM
Disclaimer with Predetermined Text"ONCE-DAILY" AND "VILOXAZINE EXTENDED-RELEASE CAPSULES 100 MG 150 MG 200 MG"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 22, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSupernus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Party NameSupernus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Monday, August 29, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 29, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 29, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 27, 2022SOU EXTENSION 1 GRANTED
Thursday, January 27, 2022SOU EXTENSION 1 FILED
Thursday, January 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 28, 2021LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 28, 2021ASSIGNED TO LIE
Wednesday, April 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 27, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, April 27, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 27, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, April 27, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, April 26, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, April 20, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, April 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 5, 2021EXAMINER'S AMENDMENT ENTERED
Monday, April 5, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 5, 2021EXAMINERS AMENDMENT E-MAILED
Monday, April 5, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 30, 2021ASSIGNED TO EXAMINER
Wednesday, December 23, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 22, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 2, 2020NEW APPLICATION ENTERED